Navigation Links
Multiple Dose Clinical Trial of TorreyPines Therapeutics' Tezampanel Demonstrates Compound is Safe and Well-Tolerated
Date:2/5/2008

rom the study and reported adverse events were generally mild and transient.

"This study is an important step forward in the clinical development of tezampanel. Our ability to safely deliver multiple doses of tezampanel means that we can now pursue virtually any indication that requires chronic dosing," said Neil Kurtz, M.D., President and Chief Executive Officer of TorreyPines Therapeutics. "There is an emerging appreciation of the pathological effects of increased AMPA and kainate receptor activation by glutamate. By blocking both receptors, tezampanel and its oral prodrug, NGX426, may represent a unique and effective approach to treat a variety of chronic pain as well as non-pain conditions."

Tezampanel is the first AMPA/kainate antagonist to be studied in clinical trials for chronic pain. Both tezampanel and NGX426 represent a novel, non-opiod, non-vascular and non-serotonergic approach to treating multiple chronic pain conditions. Tezampanel and NGX426 are antagonists of a subgroup of glutamate receptors referred to as AMPA and kainate. These receptors are found in areas of the central and peripheral nervous system that are important for the transmission of pain. For example, during a migraine attack, levels of glutamate increase and activate these receptors, facilitating the transmission of pain impulses. Tezampanel, by blocking the binding of glutamate to these receptors, is believed to inhibit the transmission of pain signals that lead to migraine headaches. The blockade of similar receptors in other regions of the brain or spinal cord has been shown in animal models to attenuate pathophysiological processes such as the muscle spasticity and rigidity that occurs following stroke and spinal cord injury, or that may be associated with multiple sclerosis.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of small mo
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
4. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
5. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
6. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
7. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
8. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
9. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
10. Conatus Pharmaceuticals Reports Positive Results of CTS-1027 in Multiple Preclinical Studies of Liver Disease
11. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014  Remedy Informatics, the leading provider of ... life sciences research, announced that it has teamed ... build the first-ever national patient registry devoted to ... "The National Pancreas Foundation is a ... and committed organizations can effect upon society as ...
(Date:7/14/2014)... , July 14, 2014  Celsion Corporation (NASDAQ: ... that the Company will ring the NASDAQ Stock Market closing ... New York, NY . President ... the Celsion and EGEN management teams will participate in the ... ET.  A live webcast will be available at https://new.livestream.com/nasdaq/live ...
(Date:7/14/2014)... Minn. , July 14, 2014  Today, ATS ... announced that it acquired the assets of MicroTest Labs, ... The acquisition of MTL is the first step in ... chemistry laboratory services platform to support the medical device ... known as Accuratus Lab Services , a name ...
Breaking Medicine Technology:Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014 2Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014 3ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 2ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 3
... /PRNewswire-iReach/ -- Today Enroute Systems Corporation ... last mile postal service delivery service options for its ... existing support of multiple global and regional carrier parcel ... businesses and residences in over 220 countries through their ...
... 31, 2012 Medical Alarm Concepts Holding, Inc. (OTCQB: ... subsequent order as part of a large ongoing commitment ... purchase order, which will be delivered in monthly installments ... date. "In November 2011, we announced a ...
Cached Medicine Technology:Enroute Adds Last Mile Postal Service Delivery Services 2Enroute Adds Last Mile Postal Service Delivery Services 3Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 2Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 3Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 4
(Date:7/14/2014)... 14, 2014 Documented Legacy , a ... the publication of its first military memoir about a World ... Thursday in October 1943 and 19 months as a prisoner ... and build the American dream. , From the Top ... dream (Amazon) is a true life story of ...
(Date:7/14/2014)... 14, 2014 Seven promising startup ... healthcare problems have been accepted into the ... Accelerator (DHA). , The awardees were selected ... multi-stage process. They include Biomeme, Fitly, Life Patch, ... (from France) and Pulse InfoFrame (from Canada) —both ...
(Date:7/14/2014)... 2014 According to a new market ... (GaN, SiC, and Others), Devices (Power IC, Power Module ... Forecast to 2014 - 2020", the Power Electronics market ... power electronics market is valued at $36.86 Billion and ... 2014- 2020. The report also includes an in-depth analysis ...
(Date:7/14/2014)... Dallas, TX (PRWEB) July 14, 2014 ... transcatheter heart valves market in Americas. The analysis ... over the 2007–2020 period and key company share ... countries: US, Canada, Brazil and Mexico. It uses ... and secondary research and in-house analysis. , Scope, ...
(Date:7/14/2014)... July 13, 2014 (HealthDay News) -- Along with improving ... with Alzheimer,s disease and other types of dementia, a ... quality of life, the researchers said. "These preliminary ... of benefits for people with dementia and their loved ... of Case Western Reserve University and University Hospitals Case ...
Breaking Medicine News(10 mins):Health News:Mount Laurel-based Documented Legacy to Release Military Memoir of World War II Air Force Vet Who Survived Black Thursday Crash 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 2Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 3Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 4Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 5Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2
... the McEwen Centre for Regenerative Medicine, Toronto General Hospital, researchers ... specific repair cells from the bone marrow to the affected ... been known that bone marrow cells have the ability to ... not been known until now is the critically important role ...
... that analyzed nearly 22,000 U.S men for a good 14 ... and keeping tabs on the body weight has an impact ... , ,Dr. Eric B. Rimm, co-author of the study, said ... be psychological, it has become clear that heart disease and ...
... Squibb has announced the launch of BARACLUDE? (entecavir) ... //following its approval by the Drug Controller General of ... treatment of chronic hepatitis B virus infection in adults ... of persistent elevations in serum aminotransferases (ALT or AST) ...
... into a leading diabetes management training center, not ... Afro-Asian countries//. The MV Hospital for Diabetes and ... Organization’s collaborating centre for diabetes research and training ... diverse countries as Cameroon, Tanzania, Myanmar, North Korea, ...
... rich in carbohydrates was very effective in maintaining weight loss ... be presented at the Australian //Institute of Food Science and ... conducted by the University of Melbourne research dietician Liz Delbridge ... for a period of 12 weeks. ,She and ...
... women with type 1 or 2 diabetes over a period ... of hip fracture among them//. This has helped to highlight ... population. ,According to Dr. Mohsen Janghorbani from Isfahan ... has not traditionally been considered a consequence of diabetes mellitus. ...
Cached Medicine News:Health News:Bone Marrow Cells Aid In Heart Repair 2Health News:Bone Marrow Cells Aid In Heart Repair 3Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2Health News:Diabetic Women Show Increased Risks of Hip Fracture 2